Status:

COMPLETED

Probiotic Intervention, Bile Acids and Lipid Metabolism Metabolic Profile in Healthy Overweight Subjects.

Lead Sponsor:

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

Collaborating Sponsors:

AB Biotics, SA

Conditions:

Probiotic Intervention

Eligibility:

All Genders

25-60 years

Phase:

NA

Brief Summary

Moderate hypercholesterolemia, metabolic alterations derived from overweight or obesity, and consequently and their related cardiovascular risks can be reduced through changes in lifestyle. A growing ...

Detailed Description

Sample size (N=20) was calculated according results of previous studies on plasma bile acids. The study refers to healthy overweight \[body mass index (BMI) 25.0-29.9 kg/m2\] adult men (N=10) and wome...

Eligibility Criteria

Inclusion

  • Body Mass index (BMI): Between 25 and 30 Kg / m2

Exclusion

  • Eating disorders.
  • Subjects with cardiovascular risk factors such as hypercholesterolemia (genetic or secondary), hypertension and diabetes, treated pharmacologically.
  • History of ischemic heart disease (and / or previous angina or AMI) or arrhythmia (current or previous).
  • Previous strokes and / or peripheral vascular disease.
  • Alcohol consumption greater than 60 gr / day.
  • Kidney failure (creatinine\> 2 mg / dl).
  • Presence of neoplasia.
  • Presence of systemic disease.
  • Psychiatric illness under treatment with psychotropics.
  • Unstabilized thyroid disease.
  • Having followed or being following a hypocaloric diet or regularly consumed dietary supplements for weight or constipation or cholesterol control (plant sterols, soy lecithin, omega-3 fatty acids) for 2 months prior to inclusion in the study.
  • Pregnancy or breastfeeding.
  • In current treatment with non-steroidal anti-inflammatory drugs, antiplatelet agents, fibrates or statins.

Key Trial Info

Start Date :

September 1 2020

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

February 21 2022

Estimated Enrollment :

20 Patients enrolled

Trial Details

Trial ID

NCT05378230

Start Date

September 1 2020

End Date

February 21 2022

Last Update

June 7 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Institut Recerca-Hospital Santa Creu I Sant Pau

Barcelona, Spain, 08025